Noriyuki Tomiyasu

Noriyuki Tomiyasu

Auto-generated profile, based on publicly available information

Noriyuki Tomiyasu

Department of Systems Life Sciences, Graduate School of Systems Life Sciences, Kyushu University, Fukuoka, Japan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2022 in Tuberculosis
Verified
Journal Article
Closed access
NNNaoya Nishimura
Naoya Nishimura
NTNoriyuki Tomiyasu
Noriyuki Tomiyasu
STShota Torigoe
Shota Torigoe
SMSatoru Mizuno
Satoru Mizuno
HFHanako Fukano
Hanako Fukano
SYSho Yamasaki
Sho Yamasaki

20 December 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
YHYuki Hosono
Yuki Hosono
NTNoriyuki Tomiyasu
Noriyuki Tomiyasu
HKHayato Kasai
Hayato Kasai
EIEri Ishikawa
Eri Ishikawa
MTMasatomo Takahashi
Masatomo Takahashi
SYSho Yamasaki
Sho Yamasaki
Invariant natural killer T (iNKT) cells are unconventional T cells recognizing lipid antigens in a CD1d-restricted manner. Among these lipid antigens, α-galactosylceramide (α-GalCer), which was originally identified in marine sponges, is the most potent antigen. Although the presence of α-anomeric hexosylceramide and microbiota-derived branched α-GalCer is reported, antigenic α-GalCer has not been identified in mammals. Here, we developed a high-resolution separation and detection system, supercritical fluid chromatography tandem mass spectrometry (SFC/MS/MS), that can discriminate hexosylceramide diastereomers (α-GalCer, α-GlcCer, β-GalCer, or β-GlcCer). The B16 melanoma tumor cell line does not activate iNKT cells; however, ectopic expression of CD1d was sufficient to activate iNKT cells without adding antigens. B16 melanoma was unlikely to generate iNKT cell antigens; instead, antigen activity was detected in cell culture serum. Activity-based purification and SFC/MS/MS identified dihydrosphingosine-based saturated α-GalCer as an antigenic component in serum, bile, and lymphoid tissues. These results show the first evidence for the presence of potent antigenic α-GalCer in mammals.

1 January 2022 in Journal of Bioscience and Bioengineering
Verified
Journal Article
Closed access
YSYuki Soma
Yuki Soma
MTMasatomo Takahashi
Masatomo Takahashi
YFYuri Fujiwara
Yuri Fujiwara
NTNoriyuki Tomiyasu
Noriyuki Tomiyasu
MGMaiko Goto
Maiko Goto
TBTAKESHI BAMBA
TAKESHI BAMBA

22 June 2025 in Journal of Chromatography A
Verified
Journal Article
Closed access
NTNoriyuki Tomiyasu
Noriyuki Tomiyasu
YIYoshihiro Izumi
Yoshihiro Izumi
OHOmidreza Heraviadeh
Omidreza Heraviadeh
MTMasatomo Takahashi
Masatomo Takahashi
TBTAKESHI BAMBA
TAKESHI BAMBA